Enabling value creation by empowering international companies to expand and control their new business in China.

Analyzing,Toxic,Substsnce Analyzing,Toxic,Substsnce

GIBF partners with select companies from Israel, Europe and the USA to establish new JVs in the Chinese market, enabling the foreign companies to manage the new enterprises as the majority shareholders.

Based in the Greater Bay Area of South China, GIBF offers international companies the resources and expertise to create value in their JVs through multiple channels, such as expanding and expediting their global clinical trials, early entry into the Chinese market, IPO in Hong Kong under the new Biotech18-A chapter introduced by the SEHK in 2018 or similar channels planned in Chinese stock exchanges, and local M&A and licensing deals.

Unique Value Proposition

Proven Investment Model
JV investment model brings foreign companies to China and adopts advanced technologies with local demands, integrating Israeli enterpenueship with Chinese talents, combining risk mitigation with multiple exit options.
Access to Deal Flow
Unparalleled access to top tier Israeli & European early stage and growth innovative high tech companies.
Highly experienced Israel and China based team, with strong track record and exceptional reputation.
Chinese Governmental Backing
Solid and effective partnership with Chinese government .

Proven Investment Model

Parent Company

The Parent Company provides a full IP rights for its technology for the Chinese market, know-how/expertise, as well as management

Dual Exit Strategy

1. JV Exit: M&A or public offering in China -HKEX (Chapter 18A Hong Kong
2. Conversion Mechanism: GIBF has the option to convert shares from the JV into shares of Parent Company in event of exit of Parent Company

The Joint Venture

The joint venture builds end-to-end business operations in China including R&D, manufacturing, marketing and sales

Proven Investment Model

GIBF ensures successful Chinese market access with financial, regulatory, R&D, manufacturing, policy, operational and network support

Unique Source

Cooperate with top tier VCs in Israel and Europe, selecting targets suitable for the Chinese market.

Investment Model

GIBF establishes alongside international healthcare companies Joint Ventures in China and obtains the exclusive patent of China with a relatively small amount of investment